Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
326 Hence, loss of GIPR signalling may play a role in the pathogenesis of insulin resistance and the manifestation of obesity
10,11,13 Such effects of GIP RAs and dual agonists are still under investigation
The good news is that you can meet your nutrient needs through whole foods, even while on a GLP-1 medication
Minimizing ultra-processed foods appears important for maintaining overall metabolic health
Our team at Atlanta Bariatrics can help you navigate insurance questions and explore options, including compounded alternatives that may be more affordable if your insurance doesn't provide coverage